Related Experiment Video
Updated: Mar 6, 2026
07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
12.4K
Radiotherapy-Chemotherapy Combinations in Locally Advanced Head and Neck Squamous Cell Carcinoma
1Graduate School of Xiangya Hospital, Central South University, Hunan, China.
Summary
This network meta-analysis on locally advanced head and neck squamous cell carcinoma (LA-HNSCC) found pembrolizumab plus radiotherapy showed a trend toward improved survival. Toxicity risks were manageable, unlike cisplatin and immunotherapy combinations.
Area of Science:
- Oncology
- Radiotherapy Research
- Clinical Trial Analysis
Background:
- Locally advanced head and neck squamous cell carcinoma (LA-HNSCC) requires effective treatment strategies.
- Radiotherapy is a cornerstone treatment, often combined with systemic therapies.
Purpose of the Study:
- To compare the efficacy and safety of radiotherapy combined with different therapeutic strategies in LA-HNSCC.
- To synthesize evidence from randomized controlled trials (RCTs) using network meta-analysis (NMA).
Main Methods:
- Conducted a Bayesian network meta-analysis of 14 RCTs involving over 5,900 patients.
- Assessed overall survival (OS), progression-free survival (PFS), and grade ≥3 toxicities.
- Performed sensitivity analyses to ensure robustness of findings.
Main Results:
- Pembrolizumab plus radiotherapy demonstrated a non-significant trend towards improved OS and PFS.
- The combination of pembrolizumab and radiotherapy showed manageable toxicity.
- Radiotherapy with cisplatin and immunotherapy exhibited higher toxicity rates.
Conclusions:
- Optimizing radiotherapy and combination therapies is crucial for LA-HNSCC treatment.
- Identifying predictive biomarkers is essential for personalized treatment approaches.
- Further research into novel therapeutic combinations is warranted.
Related Concept Videos
02:49Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
752
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
752
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K